Since the Centrinone was a selective and reversible PLK4 inhibitor with the lowest Ki values among all known inhibitors, in this study the Centrinone was used to treat AML cell lines to explore roles and mechanisms of PLK4 in the pathology of AML. The gene discussed is PLK4; the disease is acute myeloid leukemia.